Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Auspex Pharmaceuticals, Inc.Financial_Report.xls
EX-31 - EX-31.1 - Auspex Pharmaceuticals, Inc.aspx-ex31_2014063087.htm
EX-10 - EX-10.30 - Auspex Pharmaceuticals, Inc.aspx-ex10_2014063090.htm
10-Q - 10-Q - Auspex Pharmaceuticals, Inc.aspx-10q_20140630.htm
EX-31 - EX-31.2 - Auspex Pharmaceuticals, Inc.aspx-ex31_2014063089.htm

Exhibit 32.1

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350, as adopted), Pratik Shah, Ph.D., the Chief Executive Officer of Auspex Pharmaceuticals, Inc. (the “Company”), and John Schmid, the Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1.

The Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

2.

The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 7, 2014

 

 

 

/s/ Pratik Shah

 

 

Pratik Shah, Ph.D.

 

 

President, Chief Executive Officer

 

 

 

/s/ John Schmid

 

 

John Schmid

 

 

Chief Financial Officer

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Auspex Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.